Resultats de la cerca - Naveenchandra Suryadevara
- Mostrar 1 - 20 resultats de 23
- Anar a la pàgina següent
-
1
-
2
-
3
LRRK2 and RIPK2 Variants in the NOD 2-Mediated Signaling Pathway Are Associated with Susceptibility to Mycobacterium leprae in Indian Populations per Patrick Marcinek, Aditya Nath Jha, Vidyagouri Shinde, S. J. Arun, R. Rajkumar, Naveenchandra Suryadevara, Sanjeev Kumar Neela, Hoang Văn Tong, Vellingiri Balachander, Vijaya Lakshmi Valluri, Kumarasamy Thangaraj, Thirumalaisamy P. Velavan
Publicat 2013Artigo -
4
Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines per Daniel Shae, Jessalyn J. Baljon, Mohamed Wehbe, Plamen P. Christov, Kyle W. Becker, Amrendra Kumar, Naveenchandra Suryadevara, Carcia S. Carson, Christian R. Palmer, Frances C. Knight, Sebastian Joyce, John T. Wilson
Publicat 2020Artigo -
5
Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8<sup>+</sup> Lung-Resident Memory T Cells per Frances C. Knight, Pavlo Gilchuk, Amrendra Kumar, Kyle W. Becker, Sema Sevimli, Max E. Jacobson, Naveenchandra Suryadevara, Lihong Wang-Bishop, Kelli L. Boyd, James E. Crowe, Sebastian Joyce, John T. Wilson
Publicat 2019Artigo -
6
Structural mapping of antibody landscapes to human betacoronavirus spike proteins per Sandhya Bangaru, Aleksandar Antanasijevic, Nurgun Kose, Leigh M. Sewall, Abigail M. Jackson, Naveenchandra Suryadevara, Xiaoyan Zhan, Jonathan L. Torres, Jeffrey Copps, Alba Torrents de la Peña, James E. Crowe, Andrew B. Ward
Publicat 2022Artigo -
7
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein per Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, Laura A. VanBlargan, Elad Binshtein, Seth J. Zost, Rachel S. Nargi, Rachel E. Sutton, Emma S. Winkler, Elaine C. Chen, Mallorie E. Fouch, Edgar Davidson, Benjamin J. Doranz, Robert H. Carnahan, Larissa B. Thackray, Michael S. Diamond, James E. Crowe
Publicat 2021Pré-impressão -
8
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking per Andrea R. Shiakolas, Kevin J. Kramer, Nicole V. Johnson, Steven C. Wall, Naveenchandra Suryadevara, Daniel Wrapp, Sivakumar Periasamy, Kelsey A. Pilewski, Nagarajan Raju, Rachel S. Nargi, Rachel E. Sutton, Lauren Walker, Ian Setliff, James E. Crowe, Alexander Bukreyev, Robert H. Carnahan, Jason S. McLellan, Ivelin S. Georgiev
Publicat 2022Artigo -
9
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein per Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, Laura A. VanBlargan, Elad Binshtein, Seth J. Zost, Rachel S. Nargi, Rachel E. Sutton, Emma S. Winkler, Elaine C. Chen, Mallorie E. Fouch, Edgar Davidson, Benjamin J. Doranz, Rita E. Chen, Pei‐Yong Shi, Robert H. Carnahan, Larissa B. Thackray, Michael Diamond, James E. Crowe
Publicat 2021Artigo -
10
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine per Kevin J. Kramer, Erin M. Wilfong, Kelsey Voss, Sierra Barone, Andrea R. Shiakolas, Nagarajan Raju, Caroline E. Roe, Naveenchandra Suryadevara, Lauren Walker, Steven C. Wall, Ariana Paulo, Samuel Schaefer, Debolanle O. Dahunsi, Camille S. Westlake, James E. Crowe, Robert H. Carnahan, Jeffrey C. Rathmell, Rachel H. Bonami, Ivelin S. Georgiev, Jonathan M. Irish
Publicat 2022Artigo -
11
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer per Naveenchandra Suryadevara, Andrea R. Shiakolas, Laura A. VanBlargan, Elad Binshtein, Rita E. Chen, James Brett Case, Kevin J. Kramer, Erica Armstrong, Luke Myers, Andrew Trivette, Christopher Gainza, Rachel S. Nargi, Christopher N. Selverian, Edgar Davidson, Benjamin J. Doranz, Summer M. Diaz, Laura S. Handal, Robert H. Carnahan, Michael Diamond, Ivelin S. Georgiev, James E. Crowe
Publicat 2022Artigo -
12
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition per Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, Seth J. Zost, Elad Binshtein, Andrea N. Loes, Sarah K. Hilton, John Huddleston, Rachel Eguia, Katharine H. D. Crawford, Adam S. Dingens, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Paul W. Rothlauf, Zhuoming Liu, Sean P. J. Whelan, Robert H. Carnahan, James E. Crowe, Jesse D. Bloom
Publicat 2020Pré-impressão -
13
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition per Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, Seth J. Zost, Elad Binshtein, Andrea N. Loes, Sarah K. Hilton, John Huddleston, Rachel Eguia, Katharine H. D. Crawford, Adam S. Dingens, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Paul W. Rothlauf, Zhuoming Liu, Sean P. J. Whelan, Robert H. Carnahan, James E. Crowe, Jesse D. Bloom
Publicat 2020Artigo -
14
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface per Seth J. Zost, Jinhui Dong, Iuliia M. Gilchuk, Pavlo Gilchuk, Natalie J. Thornburg, Sandhya Bangaru, Nurgun Kose, Jessica A. Finn, Robin G. Bombardi, Cinque Soto, Elaine C. Chen, Rachel S. Nargi, Rachel E. Sutton, Ryan P. Irving, Naveenchandra Suryadevara, Jonna B. Westover, Robert H. Carnahan, Hannah L. Turner, Sheng Li, Andrew B. Ward, James E. Crowe
Publicat 2021Artigo -
15
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals per Elaine C. Chen, Pavlo Gilchuk, Seth J. Zost, Naveenchandra Suryadevara, Emma S. Winkler, Carly R. Cabel, Elad Binshtein, Rita E. Chen, Rachel E. Sutton, Jessica Rodríguez, Samuel B. Day, Luke Myers, Andrew Trivette, Jazmean K. Williams, Edgar Davidson, Shuaizhi Li, Benjamin J. Doranz, Samuel K. Campos, Robert H. Carnahan, Curtis A. Thorne, Michael Diamond, James E. Crowe
Publicat 2021Artigo -
16
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein per Seth J. Zost, Pavlo Gilchuk, Rita E. Chen, James Brett Case, Joseph X. Reidy, Andrew Trivette, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Elaine C. Chen, Elad Binshtein, Swathi Shrihari, Mario Ostrowski, Helen Y. Chu, Jonathan E. Didier, Keith W. MacRenaris, Taylor Jones, Samuel B. Day, Luke Myers, F. Eun-Hyung Lee, Doan C. Nguyen, Igñacio Sanz, David R. Martinez, Ralph S. Baric, Larissa B. Thackray, Michael Diamond, Robert H. Carnahan, James E. Crowe
Publicat 2020Pré-impressão -
17
SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies per Michael Diamond, Rita Chen, Xuping Xie, James Brett Case, Xianwen Zhang, Laura A. VanBlargan, Yang Liu, Jianying Liu, John M. Errico, Emma S. Winkler, Naveenchandra Suryadevara, Stephen Tahan, Jackson S. Turner, Wooseob Kim, Aaron J. Schmitz, Mahima Thapa, David Wang, Andrianus Boon, Dora Pinto, Rachel M. Presti, Jane A. O’Halloran, Alfred H.J. Kim, Parakkal Deepak, Daved H. Fremont, Davide Corti, Herbert W. Virgin, James E. Crowe, Lindsay Droit, Ali H. Ellebedy, Pei‐Yong Shi, Pavlo Gilchuk
Publicat 2021Pré-impressão -
18
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions per Andrea R. Shiakolas, Kevin J. Kramer, Daniel Wrapp, Simone I. Richardson, Alexandra Schäfer, Steven C. Wall, Nianshuang Wang, Katarzyna Janowska, Kelsey A. Pilewski, Rohit Venkat, Robert Parks, Nelia P. Manamela, Nagarajan Raju, Emilee Friedman Fechter, Clinton Holt, Naveenchandra Suryadevara, Rita E. Chen, David R. Martinez, Rachel S. Nargi, Rachel E. Sutton, Julie E. Ledgerwood, Barney S. Graham, Michael Diamond, Barton F. Haynes, Priyamvada Acharya, Robert H. Carnahan, James E. Crowe, Ralph S. Baric, Lynn Morris, Jason S. McLellan, Ivelin S. Georgiev
Publicat 2021Artigo -
19
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals per Seth J. Zost, Pavlo Gilchuk, James Brett Case, Elad Binshtein, Rita E. Chen, Joseph X. Reidy, Andrew Trivette, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Lauren E. Williamson, Elaine C. Chen, Taylor Jones, Samuel B. Day, Luke Myers, Ahmed O. Hassan, Natasha M. Kafai, Emma S. Winkler, Julie M. Fox, James J. Steinhardt, Kuishu Ren, Yueh–Ming Loo, Nicole L. Kallewaard, David R. Martinez, Alexandra Schäfer, Lisa E. Gralinski, Ralph S. Baric, Larissa B. Thackray, Michael Diamond, Robert H. Carnahan, James E. Crowe
Publicat 2020Pré-impressão -
20
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 per Matthew C. Woodruff, Richard P. Ramonell, Doan C. Nguyen, Kevin S. Cashman, Ankur Singh Saini, Natalie S. Haddad, Ariel M. Ley, Shuya Kyu, J. Christina Howell, Tuğba Öztürk, Saeyun Lee, Naveenchandra Suryadevara, James Brett Case, Regina Bugrovsky, Weirong Chen, Jacob Estrada, Andrea Morrison-Porter, Andrew Derrico, Fabliha A. Anam, Monika Sharma, Henry M. Wu, Sang Le, Scott A. Jenks, Christopher M. Tipton, Bashar S. Staitieh, John L. Daiss, Eliver Ghosn, Michael Diamond, Robert H. Carnahan, James E. Crowe, William T. Hu, F. Eun‐Hyung Lee, Igñacio Sanz
Publicat 2020Artigo
Eines de cerca:
Matèries relacionades
Biology
Immunology
Antibody
Virology
Medicine
Coronavirus disease 2019 (COVID-19)
Disease
Infectious disease (medical specialty)
Gene
Genetics
Pathology
Monoclonal antibody
Epitope
Immune system
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Antigen
Coronavirus
Recombinant DNA
Virus
Computational biology
Computer science
Neutralization
Neutralizing antibody
Spike Protein
Chemistry
Epitope mapping
Mutation
Polyclonal antibodies
2019-20 coronavirus outbreak
Biochemistry